Xsensio is building the breakthrough Lab-on-SkinTM wearable: a modular miniaturized sensing platform that will offer unique health insight through the continuous and real-time analysis of proteins and hormones at the surface of the skin during critical health events, to improve standard of care in a simple and minimally-invasive way.
Xsensio considerably expands the potential of wearable products with the development of a breakthrough wearable device that tracks – not physical data like today’s devices – but biochemical data in the interstitial fluid (ISF).
"It was a pleasure to welcome Xensio into the 2022 MedTech Accelerator cohort. These kinds of breakthrough technologies have the potential to dramatically improve healthcare outcomes with the feedback offered by the subject matter experts we helped Xensio connect with."
Director, Arizona State University